Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 30, 2019 - Issue 6
Submit an article Journal homepage
282
Views
4
CrossRef citations to date
0
Altmetric
Hair and pigment

A clinical and immunological study of phototoxic regimen of ultraviolet A for treatment of alopecia areata: a randomized controlled clinical trial

Medhat El-MoftyDermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt;
,
Hoda RasheedDermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt;
,
Nermin El-EishyDermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt;
,
Rehab A. HegazyDermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt;
,
Vanessa HafezDermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt; Correspondence[email protected]
,
Olfat ShakerMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
&
Solwan I. El-SamanoudyDermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt;
show all
Pages 582-587 | Received 27 Sep 2018, Accepted 27 Oct 2018, Published online: 08 Jan 2019

References

  • Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update. Part II. Treatment. J Am Acad Dermatol. 2010;62(2):191–202. quiz 203-4.
  • Garg S, Messenger AG. Alopecia areata: evidence-based treatments. Semin Cutan Med Surg. 2009;28:15–18.
  • Gregoriou S, Papafragkaki D, Kontochristopoulos G, et al. Cytokines and other mediators in alopecia areata. Mediators Inflamm. 2010;2010:928030.
  • Ito T, Ito N, Saathoff M, et al. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol. 2005;152:623–631.
  • Delamere FM, Sladden MJ, Dobbins HM, et al. Interventions for alopecia areata. Cochrane Database Syst Rev. 2008;(2):CD004413.
  • Healy E, Rogers S. PUVA treatment for alopecia areata-does it work? A retrospective review of 102 cases. Br J Dermatol. 1993;129:42–44.
  • Kamel MM, Salem SAM, Attia HHM. Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8-methoxypsoralen application. Photodermatol Photoimmunol Photomed. 2011;27:45–50.
  • Mohamed Z, Bhouri A, Jallouli A, et al. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen. J Eur Acad Dermatol Venereol.. 2005;19:552–555.
  • Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
  • Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines–Part II. J Am Acad Dermatol. 2004;51:440–447.
  • Deeths MJ, Endrizzi BT, Irvin ML, et al. Phenotypic analysis of T-cells in extensive alopecia areata scalp suggests partial tolerance. J Invest Dermatol. 2006;126:366–373.
  • Cerwenka A, Swain SL. TGF-beta1: immunosuppressant and viability factor for T lymphocytes. Microbes Infect. 1999;1:1291–1296.
  • Paus R, Ito N, Takigawa M, et al. The hair follicle and immune privilege. J Investig Dermatol Symp Proc. 2003;8:188–194.
  • Paus R, Nickloff B, Ito T. A ‘hairy’ privilege. Trends Immunol. 2005;26:32–40.
  • Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem. 2010;147:781–792.
  • Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc.. 2013;16:S13–S15.
  • Stewart CE, Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem. 1996;271:11330–11338.
  • Musarò A, Rosenthal N. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol Cell Biol. 1999;19:3115–3124.
  • Hsieh AC, Bo R, Manola J, et al. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 2004;32:893–901.
  • Tezuka M, Ito M, Ito K, et al. Cell kinetic study of human and mouse hair tissues using anti-bromodeoxyuridine monoclonal antibody. J Dermatol Sci. 1990;1;1:335–346.
  • Philpott MP, Sanders DA, Bowen J, et al. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. Br J Dermatol. 1996;135:942–948.
  • Ito T, Ito N, Bettermann A, et al. Collapse and restoration of MHC Class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol. 2004;164:623–634.
  • Harries MJ, Sun J, Paus R, et al. Management of alopecia areata. BMJ. 2010;341:c3671.
  • Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol. 2006;55:438–441.
  • Akhyani M, Seirafi H, Hallaji Z, et al. Correlation between the severity of alopecia areata and its risk factors. Iran J Dermatology. 2011;14:6–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.